Skip to Main Content

Paper Details

BRCA mutations lead to XIAP overexpression and sensitise ovarian cancer to inhibitor of apoptosis (IAP) family inhibitors.
Br J Cancer
4
2022
BRCA, BRCA1, BRCA1-mutated, BRCA1-mutated cancers, BRCA1-mutated cell line, BRCA1-mutated cell lines, BRCA2, Cell lines, IAP, IAP proteins, LCL161, NF-kB, PARP, PDX, PDX mouse models, X-linked inhibitor of apoptosis, XIAP, antitumour, cancers, cell lines, human, inhibitor of apoptosis, inhibitor of apoptosis family, mouse, ovarian cancer, ovarian cancers, patient, platinum, resistant BRCA2 and 1-mutated ovarian cancer
Author NameAffiliation
David G Huntsman
David G HuntsmanUniversity of British Columbia
David G Huntsman
David G HuntsmanUniversity of British Columbia
  • 1 - 4

Datasets

Release 1.2